Post Sourcing Request Exhibition
AVT (Shanghai) Pharmaceutical Tech Co., Ltd.
Four years of qualification Audited Supplier

In This Store

  • In This Store
  • On Pharma Sources.com
Favorites
You are here:   Home > Suppliers > AVT (Shanghai) Pharmaceutical Tech Co., Ltd. > news

News of AVT (Shanghai) Pharmaceutical Tech Co., Ltd.

10

FEB-2022

Advantages and disadvantages of DOTMA in RNA liposomes

10

FEB-2022

Cationic Lipid DOTMA

10

FEB-2022

Wen Daxiang, and his delegation visited AVT for investigation

10

FEB-2022

Registration number of AVT sucrose F20200000093 was officially announced

10

FEB-2022

Synthetic phospholipid DSPC can be applied to various pharmaceutical preparations such as liposomes

10

FEB-2022

DLin-MC3-DMA, a key excipient for nucleic acid delivery, can ionize cationic lipids

10

FEB-2022

Application and safety analysis of DOTAP, a key excipient for nucleic acid delivery

10

FEB-2022

Phospholipid polyethylene glycol biotin/DSPE-PEG2000-Biotin product information

1 2 3 4 5 6 ... 9 10

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service